Dirk Huebner
Hoofd Techniek/Wetenschap/O&O bij APTEVO THERAPEUTICS INC.
Profiel
Dirk Huebner is currently the Chief Medical Officer at Aptevo Therapeutics, Inc. He previously worked as the Executive Medical Director at Millennium Pharmaceuticals, Inc. from 2011 to 2017, as the Vice President at Boston Biomedical, Inc. from 2017 to 2018, and as the Chief Medical Officer at Mersana Therapeutics, Inc. from 2018 to 2020.
He holds a doctorate degree from Freie Universität Berlin.
Actieve functies van Dirk Huebner
| Bedrijven | Functie | Begin |
|---|---|---|
| APTEVO THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Dirk Huebner
| Bedrijven | Functie | Einde |
|---|---|---|
| MERSANA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 30-11-2020 |
Boston Biomedical, Inc.
 Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The private company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Corporate Officer/Principal | 01-11-2018 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-08-2017 |
Opleiding van Dirk Huebner
| Freie Universität Berlin | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MERSANA THERAPEUTICS, INC. | Health Technology |
| APTEVO THERAPEUTICS INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Boston Biomedical, Inc.
Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The private company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Commercial Services |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
